D. E. Shaw & Co., Inc. Cv Rx, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Cv Rx, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 45,269 shares of CVRX stock, worth $586,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,269
Previous 59,059
23.35%
Holding current value
$586,686
Previous $520,000
10.19%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$53.2 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$26.3 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$11.9 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$11.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$11.3 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $267M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...